 Shares of Germany-based BioNTech SE BNTX, 2.64 surged 5.1 toward a three-month high in premarket trading Friday, after The Wall Street Journal reported that China agreed to approve the biotechnology companys COVID-19 vaccines for foreign residents in China. Pfizer Inc.s stock PFE, -0.21 climbed 1.5 ahead of the open, as BioNTech had partnered with the U.S. drug giant to develop COVID-19 vaccines. 